Start here
Muse cells aren't a separate, better product added to a stem cell culture. They're the small number of unusual cells already living inside an ordinary one — about two or three in every hundred. A Muse cell product is that same culture, with one extra step: someone found those few cells and pulled them out.
Muse cells — naturally about 2 in 100 Ordinary MSCs — the other 98
Why “how much” is the wrong question
Turning that culture into a real Muse product isn't a matter of degree — a lab either ran the sorting step that separates those cells out, or it didn't. There's no such thing as “a little bit sorted.” Skip the step, and the vial still has exactly the two or three cells in a hundred it started with; the rest is still an ordinary stem cell culture, whatever the label says.
Ordinary MSC therapy
Grown and used as a mixed population — Muse cells included, still scattered through it, never separated out.
A genuine Muse cell product
The same starting material, put through a sorting process that physically pulls the Muse fraction out and concentrates it on its own.
Why this matters more than anything else on this site
“Muse cells” is a scientific description, not a protected product name. Any laboratory can print it on a label, and there is no regulator checking. Two vials that say the same thing can contain very different products — and the only way to know which you have is a lab test on that specific batch, not a bigger percentage on the marketing page.
The questions people actually ask
Why would I want this
In early human studies, Muse cells have shown a good safety record and some encouraging early signals — improved recovery scores after stroke and spinal cord injury, better heart pumping after a heart attack, tolerable use with no rejection even from an unmatched donor. Nothing here is a promise. It's a set of small, early studies pointing somewhere worth watching.
What it isn't (yet)
Nobody has shown they work better than an ordinary stem cell treatment — that comparison has never been run. Nobody has proven they work at all in a large trial. And nothing containing them is approved by any regulator, anywhere, for any condition. Anyone promising a cure is ahead of the evidence.
The decision that's actually yours
Because the reason to prefer it is real, if you accept it on its own terms: these are the only cells shown to home past the lungs to injury, with a clean safety record and no donor matching — and the claim they're proven better is not part of that. Both are true at once. This site's job is to help you decide with both of them in view, and to make sure whatever you buy is what the label says.
The short version
You already have them. Muse cells occur naturally in bone marrow, fat, skin and blood — roughly one to three cells in every hundred of an ordinary mesenchymal stem cell culture. They were first described by researchers at Tohoku University in Japan in 2010.
Tough
The name means “multilineage-differentiating stress-enduring.” They tolerate harsh conditions that ordinary cells do not — which is how laboratories begin to separate them out.
Directed
Damaged tissue releases a chemical distress signal. In animal studies, Muse cells follow that signal through the bloodstream to the injured area.
Adaptable
In the laboratory they have been turned into cells from all three major tissue families — nerve, muscle and heart, and the linings of internal organs.
Being straight with you
Plenty of websites will tell you Muse cells are proven to work better than ordinary stem cell therapy. We are not going to, because the studies that would show that have not been done. Here is the honest position, and we would rather you hear it from us than find it out later.
Genuinely encouraging
Across every published human study, no tumours formed and no patient's immune system rejected the cells — even when the cells came from an unmatched donor and no anti-rejection drugs were used. That is a real achievement.
Genuinely unproven
No study has ever compared Muse cells against ordinary stem cells in patients, for any condition. Every claim that one is better than the other is an expectation based on laboratory work, not a result measured in people.
Still early
Six published studies, about 67 patients in total, and only one of those compared treatment against a dummy treatment. For context, ordinary stem cells have been through roughly 1,850 registered trials.
Important to know
No Muse cell product is approved by the FDA, or by any regulator in any country. Anything offered to you commercially sits outside that approval system.
Our own number, while we're being honest
The batches we currently supply run roughly 10% Muse cells to 90% MSCs — a partial separation, not the full sorting described above. That's a plain statement about what we ship today, not a claim that it's the ideal ratio or that a higher one would be worse. If our supply changes, this number changes with it.
The case for Muse, made honestly
“Not proven better” is not the same as “no reason to prefer it.” The case for Muse cells does not rest on a headline trial result — it rests on a mechanism ordinary stem cells demonstrably lack, and a safety record with no red flags so far. Here it is, in the form we'd want to hear it before spending our own money.
Reason one
Given by drip, ordinary MSCs are largely trapped in the lungs and mostly gone within a day — a documented weakness of the whole category. Muse cells are the only ones shown, in controlled animal studies, to follow a distress signal past the lungs and into the damaged tissue itself. If reaching the injury matters, this is the one cell type built for it.
Reason two
Across every published study, patients received cells from donors they didn't match, with no immunosuppressants — and no rejection episode was ever recorded. That is unusual, it matters for how these treatments can be delivered, and the human data behind it, while small, is consistently clean.
Reason three
No tumours, in roughly 67 dosed patients or in the animal studies designed to look for them. Small numbers — but in more than a decade of testing, nothing has surfaced that would make you stop. Compare that with the decades it took other cell therapies to clear the same bar.
And the honest counterweight, stated plainly: none of the three reasons above has been shown to produce better outcomes for patients. The one comparative study (stroke, 35 patients) showed a promising signal that fell short of statistical significance. If someone in your position needs certainty, the honest answer is that Muse cells don't have it yet — and neither does anything else in regenerative medicine.
So the decision becomes personal, and it should be: does an interesting mechanism and a clean safety record justify trying something investigational — with your eyes open, and with paperwork proving the vial is what it claims? Some people say yes. Some say wait for bigger trials. This site exists so that whichever you answer, you answer it knowing exactly what you're choosing between.
If someone is selling you this
“What percentage of the cells in this specific batch tested positive for SSEA-3?”
SSEA-3 is the marker that defines a Muse cell. The answer should be a number from a test on the batch you are being offered — not a brochure, not a figure from a different lot, not a description of the company's process.
A supplier who cannot answer that is selling an ordinary stem cell preparation with a Muse label on it. That may still be a legitimate product, but it should be priced and described as what it is.
